[1] Fiorentino DF.Cutaneous Vasculitis.J Am Acad Dermatol,2003,48:311-340.
[2] Sunderkotter C,Bonsmann G,Sindrilaru S,et al.Management of Leukocytoclastic vasculitis.J Dermatol Treat,2005,16:193-206.
[3] Gibson LE,Specks U.Homburger H.Clinical utility of ANCA tests for the dermatologist.Int J Dermatol,2003,42:859-869.
[4] Russell JP,Gibson LE.Primary cutaneous small vessel vasculitis:approach to diagnosis and treatment.Int J Dermatol,2006,45:3-13.
[5] Ronkainen J,Nuutinen M,Koskimies O.The adult kidney 24years offer Childhood Henoch-Schonlein purpura:a retrospective cohort study.Lancet,2002,360:666-670.
[6] Zhu YI,Stiller MJ.Dapsone and sulfones in dermatology:overview and update.J Am Acad Dermatol,2001,45:420-434.
[7] Grabbe J,Haas N,Moller A,et al.Erythema elevatum diutincom-evidence for disease-dependent leucocyte alterations and response to dapsone.Br J Dermatol,2000,143:415-420.
[8] EL-Azhary RA.Azathioprine:current status and future considerations.Int J Dermatol,2003,42:335-341.
[9] Ong CS,Benson EM.Successful treatment of chronic leukocytoclastic vasculitis and persistent ulceration with intravenous immunoglobulin.Br J Dermatol,2000,143:447-449.
[10] Weiler CR.Immunoglobulin therapy:history indications and routes of administration.Int J Dermatol,2004,43:163-166.
[11] Worm M,Sterry W,Kolde G,Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis.Br J Dermatol,2000,143:1324.
[12] Mang R,Ruzicka T,Stege H.Therapy for severe necrotizing vasculitis with inffiximab.J Am Acad Dermatol,2004,51:321-322.
[13] Uthman IW,Touma Z,Sayad J,et al.Response of deep cutaneous vasculitis to infliximab.J Am Acad Dermatol,2005,531:353-354.
[14] Cem Ar M,Soysal T,Hatemi G,et al.Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma.Ann Hematol,2005,84:609-613. |
